# Anticholinergic vs. Botox Comparison Study

> **NCT01166438** · PHASE3 · COMPLETED · sponsor: **NICHD Pelvic Floor Disorders Network** · enrollment: 249 (actual)

## Conditions studied

- Urge Urinary Incontinence
- Overactive Bladder

## Interventions

- **DRUG:** Botulinum toxin A (Botox A®)
- **DRUG:** Solifenacin 5mg
- **DRUG:** Solifenacin 10mg
- **DRUG:** Trospium chloride

## Key facts

- **NCT ID:** NCT01166438
- **Lead sponsor:** NICHD Pelvic Floor Disorders Network
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2012-05
- **Final completion:** 2012-05
- **Target enrollment:** 249 (ACTUAL)
- **Last updated:** 2018-05-02

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01166438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01166438, "Anticholinergic vs. Botox Comparison Study". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01166438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*